Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.

Similar documents
Technicians & Nurses Program

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP

OCT Interpretation in Retinal Disease

Ganglion cell analysis by optical coherence tomography (OCT) Jonathan A. Micieli, MD Valérie Biousse, MD

OCT Interpretation. Financial Disclosure. Jay M. Haynie, OD, FAAO. OCT Image Layers 7/21/2014

OCT Angiography The Next Frontier

OCT Image Analysis System for Grading and Diagnosis of Retinal Diseases and its Integration in i-hospital

The Quick Guide to OCT Mastery 50 Real Cases with Expert Analysis

Mark Dunbar: Disclosure

Past ocular history. DME Case 1. Patient presents blurred VA. Hemoglobin A1c 11.5% -- patient states sugars have not been in good control

Course # Getting to Know Your OCT

Diagnosis in AMD. Managing your AMD Patients

Clinical Case Presentation. Branch Retinal Vein Occlusion. Sarita M. Registered Nurse Whangarei Base Hospital

Retinal Complications of Obstructive Sleep Apnea A Growing Concern!

Fundus Autofluorescence. Jonathan A. Micieli, MD Valérie Biousse, MD

When optical coherence tomography (OCT)

Retina Conference. Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014

OPTIC DISC PIT Pathogenesis and Management OPTIC DISC PIT

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

International Journal of Health Sciences and Research ISSN:

Management of Neovascular AMD

EFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY

Diabetic Macular Edema Treatment in the 21st Century

ZEISS AngioPlex OCT Angiography. Clinical Case Reports

Cirrus TM HD-OCT. Details defi ne your decisions

11/29/2016 MACULAR MALADIES: TYPICAL & ATYPICAL CASES

Instudies of vascular endothelial growth factor

RETINAL CONDITIONS RETINAL CONDITIONS

ZEISS AngioPlex OCT Angiography Making the revolutionary, routine.

Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015

The College of Optometrists - Learning outcomes for the Professional Certificate in Medical Retina

evaluation of vitreoretinal adhesions in exudative AMD using optical coherence tomography

Clinically Significant Macular Edema (CSME)

Non-arteritic anterior ischemic optic neuropathy (NAION) with segmental optic disc edema. Jonathan A. Micieli, MD Valérie Biousse, MD

Intraocular Radiation Therapy for Age-Related Macular Degeneration

Why Is Imaging Critical in My Uveitis Practice?

OCT Angiography. Financial Disclosures: Pre-Test: Which one is Correct?

Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)

Diabetic Retinopatathy

8/6/17. Disclosures Aerie Pharmaceuticals Alcon BioTissue Diopsys Optovue Shire

OCT Angiography in Primary Eye Care

ACTIVATED OR NOT? RETINAL CASE PRESENTATION Shorye Payne, MD Medical Retinal Specialist Robley Rex VA Eye Clinic

Measuring of the fovea and foveola using line scans and 3D Macular scans obtained with spectral domain optical coherent tomography.

From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014

Advances in OCT Murray Fingeret, OD

P. Stavrakas MD PhD. Consultant Ophthalmologist and vitreoretinal surgeon 2 nd Department of Ophthalmology University of Athens

OCT Angiography: The Next Step in Retinal Imaging Jonathan Zelenak D.O.

R&M Solutions

VMA at the macula resulting in VMT

Practical Care of the Cataract Patient with Retinal Disease

3/6/2014. Hoda MH Mostafa MD Associate Professor of Ophthalmology Cairo University. The author has no proprietary interest. Today s Objectives

NIH Public Access Author Manuscript JAMA Ophthalmol. Author manuscript; available in PMC 2013 September 10.

Ophthalmic Imager Role

Choroidal Mapping; a Novel Approach for Evaluating Choroidal Thickness and Volume

Incorporating OCT Angiography Into Patient Care

Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment

Cirrus TM HD-OCT. Details define your decisions

The Foundation WHAT IS THE RETINA? continued next page. RETINA HEALTH SERIES Facts from the ASRS

DOME SHAPED MACULOPATHY. Ιωάννης Ν. Βαγγελόπουλος Χειρ. Οφθαλμίατρος - Βόλος

Learn Connect Succeed. JCAHPO Regional Meetings 2017

Diabetic Retinopathy: Managing the Extremes. J. Michael Jumper, MD West Coast Retina

Clinical results of OPT-302 (VEGF-C/D Trap ) Combination Treatment in namd and DME

HHS Public Access Author manuscript Ophthalmic Surg Lasers Imaging Retina. Author manuscript; available in PMC 2016 January 14.

A Comparative Study of Age Related Macular Degeneration In Relation To SD-OCTand Fundus Photography.

Citation BioMed Research International, 2015, v. 2015, article no Creative Commons: Attribution 3.0 Hong Kong License

Clinical results of OPT-302 (VEGF-C/D Trap ) Combination Treatment in namd and DME

The Foundation WHAT IS THE RETINA?

Diabetic Retinopathy

You can C-ME after Uveitis

Case Report Increase in Central Retinal Edema after Subthreshold Diode Micropulse Laser Treatment of Chronic Central Serous Chorioretinopathy

Overview. Macular OCT Artifact Study

Diabetic Retinopathy Clinical Research Network

University Hospital Basel. Optical Coherence Tomography Emerging Role in the Assessment of MS PD Dr. Konstantin Gugleta

Ophthalmology Macular Pathways

Moving forward with a different perspective

Citation. As Published Publisher. Version

Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials

References 1. Melberg NS, Thomas MA AJO 120: , Welch JC AJO 124: 698, Hirata A, Yonemura N, et al. AJO 130:611, 2000.

Spectral-domain Optical Coherence Tomography Imaging of Age-related Macular Degeneration

Retina Grandrounds. Retinal Grand Rounds Exhibition of Common Entities

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health Technology Appraisal. Aflibercept for treating diabetic macular oedema.

Anti VEGF Agents in Retinal Disorders Current Scenario

The Human Eye. Cornea Iris. Pupil. Lens. Retina

What Is O.C.T. and Why Should I Give A Rip? OCT & Me How Optical Coherence Tomography Changed the Life of a Small Town Optometrist 5/19/2014

Posterior Segment Update

Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema

History/principles of the OCT What does the normal retinal OCT look like Vitreal disorders Retinal/RPE disorders Choroidal disorders

Opthea Initiates OPT-302 Diabetic Macular Edema Clinical Trial

Retinal Diseases. Age-Related Macular Degeneration. What Is AMD? Risk Factors for AMD

Do You See What I See!!! Shane R. Kannarr, OD

Disclosures. Definitions. Goals. Imaging and glaucoma 3/22/2016

Anti-VEGF drugs & CATT Results. in AMD. Apollo Hospitals, Hyderabad. Mallika Goyal, MD

Treatment for Central-Involved Diabetic Macular Edema in Eyes with Very Good Visual Acuity

Mariam Raouf Fadel M.B., B.Ch. M.Sc., Cairo University. A thesis. Submitted by. For partial fulfillment of. MD Degree in Ophthalmology

The Wilmer Eye Institute s 34 th Annual Current Concepts in Ophthalmology March 13-17, 2017 Vail Marriott * Vail, Colorado

The Use of Intravitreal Aflibercept in the Treatment of Wet Type of Age Related Macular Degeneration

The MP-1 Microperimeter Clinical Applications in Retinal Pathologies

Use of Aflibercept in cases of recurrent or refractory neovascular AMD previously treated with other antiangiogenic drug: anatomo-functional outcomes

Vitreomacular interface disorders. Ghanbari MD 1393:10:25

Retinal Vein Occlusion (RVO) Treatment pathway- Northeast England. Retinal Vein Occlusion (RVO) with Macular oedema (MO)

Transcription:

Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D. Disclosure OCT Optical Coherence Tomography No relevant financial relationships I will refer to off-label use of medications Laser Cross section What happens when light hits the retina? What happens when light hits the retina? What happens when light hits the retina? Only 10-5 to 10-9 of incident light is reflected back. Transmission Absorption Reflection OCT images are created by What pigments are found within the eye? Ocular Pigments: melanin, xanthophylls, hemoglobin 1. Ocular pigments 2. Interfaces with differing refractive indices 1. Xanthophylls 2. Hemoglobin 3. Melanin 1

OCT Imaging = Optical Biopsy Normal Macular Anatomy Xanthophyll Highest concentration in macula What color is the retina? Melanin OCT B-Scan Normal Macular Anatomy R + T = 1 Fresnel Equations Pre-operative macular hole NFL GCL IPL OPL ONL ELM IS/OS RPE Choroid For light polarized in Ө the plane of the diagram: i R s = (sin(ө i - Ө t)/sin (Ө i + Ө t)) 2 For light polarized perpendicular to the plane of the diagram: R p = (tan (Ө i - Ө t)/tan(ө i + Ө t)) 2 Ө r Ө t Post-operative For non-polarized light: R = (R s + R p)/2 Modified from: Retina 5 th Ed, Chapter 3, Optical Coherence Tomography Within retinal tissue this is: 10-5 to 10-9 Previous vitrectomy with silicone oil 20 minutes later Aqueous 2

OCT tomogram of cervical epithelium Optical coherence tomography showing prostatic capsule and cancer cells underneath the thin layer Resolution 150 µ TD-OCT: Resolution 10 µ SD-OCT Resolution 3 to 6 µ 3.5 or 6 mm 3

Spectral Domain OCT (SDOCT) Imaging Faster image acquisition. 27000 40000 A-scans/sec: currently available instruments. 200,000 300,000 A-scans/sec: research instruments. Higher density scans over larger areas, image averaging to improve image quality, fewer eye motion artifacts. SDOCT Imaging of Macula Qualitative assessment of retinal anatomy: Subretinal Fluid PED Subretinal Fluid SDOCT Imaging of Wet AMD Segmentation of retinal layers necessary for quantitative assessments: ILM segmentation SDOCT Imaging of Wet AMD Segmentation algorithms result in reliable retinal thickness maps: Retinal thickness VA: 20/100 SDOCT Imaging of Wet AMD: Anti-VEGF Therapy Retinal thickness map Retinal thickness RPE segmentation ILM segmentation RPE segmentation RPE segmentation VA: 20/40 Anti-VEGF Therapy: 1 month post-injection SDOCT Imaging of Dry AMD Segmentation algorithms result in reliable RPE elevation (drusen) maps (Cirrus, software 6.0): SDOCT Imaging of Wet AMD Segmentation algorithms result in reliable RPE elevation (PED) maps (Cirrus, software 6.0): SDOCT Imaging of Wet AMD Vitreomacular interface abnormalities RPE RPE floor RPE RPE floor Vol: 0.58mm 3 Epiretinal membrane RPE segmentation RPE Elevation map Gregori G, Wang F, Rosenfeld PJ, et al. Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration. Ophthalmology. 2011;118(7):1373-9. RPE segmentation Retinal thickness RPE Elevation map 4

Macular edema RPED 5

Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Retina Michael Stewart, M.D. 6

Why this shadow? Why this shadow? Gas bubble 7

1945µ 2819µ 8

2 weeks later OS 20/40 Stage 2 OD 20/25 Stage 1 Lamellar hole Cyst? Lamellar hole 9

Epiretinal Membrane 20/40 Pre-Op 20/30 Post-Op 10

9/29/2005 10/31/2005 11/30/2005 11

1/11/2006 Subretinal fluid RPED Case 71 yo man with wet AMD OS Multiple injections for the last 12 months Complains of worsening in VA after treatment Case 74 y.o. man decreased vision OD (20/200) Wet AMD Dry AMD 20/200 Ranibizumab #1 Case After 1 month Case Monthly Injections 73 y.o. woman with neovascular AMD VA: 20/40 Ranibizumab #1 Vol: 0.73 mm 3 VA: 20/20 Ranibizumab #2 Case 3 65 y/o woman with a vascularized, hemorrhagic PED Vol: 0.63 mm 3 20/80 Ranibizumab #2 VA: 20/20 Ranibizumab #3 Vol: 0.56 mm 3 Color photo Early FA Late FA 12

Baseline Anti-VEGF #1, Anti-VEGF #2 4w post Inj. #2 Observed 6w post Inj. #2 Observed Volume: 6.9 mm 3 Volume: 2.6 mm 3 Case 4: Dosing Every 2 Weeks 66 year old woman 10 injections: Bev X6, Ran X4 (~q5wks) July 2007 FA-early 20/50 FA-late OCT Baseline 20/200 Ran Inj. #1 2 w post Inj. #1 20/40 Bev Inj. #2 8w post Inj. #2 Anti-VEGF #3 Volume: 3.2 mm 3 1 year later 20/200 2 w post Inj. #2 20/30 Ran Inj. #3 4w post Inj. #3 Observed Volume: 3.9 mm 3 2 w post Inj.#3 20/30 Bev Inj. #4 Volume: 1.6 mm 3 Modified from: Stewart MW, et al. Pharmacokinetic Rationale For Dosing Every 2 Weeks Versus 4 Weeks With Intravitre Ranibizumab, Bevacizumab, And Aflibercept (Vascular Endothelial Growth Factor Trap-eye). Retina. 2011 Dec 18. 13

Diagnosis? IOP = 4 OD BDR OS Pre-op Baseline 1 day Post-op Following steroid injection OD 1 month later OS 6 months VA: 20/20 c/o superior field defect 14

Acute retinal artery occlusion Inner retina thickening Retinal thinning Treatment options: 1. External beam irradiation 2. Systemic chemotherapy Treatment 1.Observation 2.Laser photocoagulation 15

NFL Lines in nasal periphery 65 y.o. s/p scleral buckle for RD Now with VA of 20/100 for 6 months. 2 nd opinion: 68 y.o with iritis and VA of 20/40 OU 16